Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery UPLEX MS Combo 1HMN
SDP

Catalog No. 5000080842
Encompass

The Meso Scale Discovery U-PLEX Multiple Sclerosis Combo 1 Human Sector K15684K is a multiplex assay kit that allows simultaneous measurement of IL-2 IL-10 IL-17A IL-17F IFN- and TNF- in human serum plasma and cell culture supernatants This electrochemiluminescence (ECL) based assay utilizes MSD s proprietary SECTOR Imager and provides high sensitivity a wide dynamic range and requires low sample volume The kit includes a 96-well plate coated with capture antibodies detection antibodies read buffer wash buffer diluent calibrators and controls This assay allows efficient quantification of multiple analytes from a single small-volume sample

Catalog No. 50-000-80842 Supplier Meso Scale Discovery Supplier No. K15684K2
May include imposed supplier surcharges.
Add to Cart
Add to Cart
Request a Quote

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX Multiple Sclerosis Combo 1 Human Sector K15684K is a multiplex assay kit that allows simultaneous measurement of IL-2 IL-10 IL-17A IL-17F IFN- and TNF- in human serum plasma and cell culture supernatants This electrochemiluminescence (ECL) based assay utilizes MSD s proprietary SECTOR Imager and provides high sensitivity a wide dynamic range and requires low sample volume The kit includes a 96-well plate coated with capture antibodies detection antibodies read buffer wash buffer diluent calibrators and controls This assay allows efficient quantification of multiple analytes from a single small-volume sample

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.